Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03683420 · ClinicalTrials.gov registry record · NA

Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment

A NA study of Malignant Neoplasm and Caregiver, sponsored by Barbara Ann Karmanos Cancer Institute.

Completed
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT03683420: Completed NA study of Malignant Neoplasm and Caregiver, sponsored by Barbara Ann Karmanos Cancer Institute.

NCT03683420 is a NA study of Malignant Neoplasm and Caregiver that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 1,000 participants, above the 496-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (102% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03683420, a NA study of Malignant Neoplasm and Caregiver, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiological wellbeing.

Primary Outcome

Clinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. Total scores are reported with the total scores ranging from 0-10; higher scores indicate more pain.

Interventions

  • BEHAVIORAL Music Therapy

Study Locations (1)

Michigan

  • Wayne State University/Karmanos Cancer Institute - Detroit

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-02-14
Est. Completion 2020-12-31
Phase NA

What the finished NCT03683420 record still lists

NCT03683420 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 496-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (102% higher).

The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Music Therapy is the first listed.

NCT03683420 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03683420 about?

NCT03683420 is a clinical study titled "Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment". This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiol...

What is the current status of trial NCT03683420?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2018-02-14. Estimated completion is 2020-12-31.

What conditions does trial NCT03683420 study?

This clinical trial studies the following conditions: Malignant Neoplasm, Caregiver.

What interventions are being tested in trial NCT03683420?

The interventions under investigation include: Music Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03683420?

This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03683420 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03683420's enrollment target sits among peer trials

1,000 6th of 59 higher than 54 of 59 other Malignant Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03683420, the US trial registry maintained by the National Library of Medicine. NCT03683420 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.